Helicobacter pylori infection. Helicobacter pylor
Conditions
Interventions
Intervention group: Patients with Helicobacter Pylori infection receiving four regimens based on levofloxacin 500 mg once daily for 14 days..
Treatment - Drugs
Intervention group: Patients with Helicobacter Pylori infection receiving four regimens based on levofloxacin 500 mg once daily for 14 days.
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Aged 18 years and older Patients with dyspepsia and upper digestive tract symptoms Peptic Ulcers in Upper Gastrointestinal Endoscopy Helicobacter pylori infection in rapid test of urease The desire to participate in the study Lack of severe illness Not having a history of upper gastrointestinal surgery Not taking antibiotics, PPIs and NSAIDs in the last three months Not having eradication history of Helicobacter pylori Absence of ContraIndications for the Consumption of quadruple therapy
Exclusion criteria
Exclusion criteria: Low drug intake (for any reason) Incidence of severe drug complications during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication of Helicobacter pylori infection. Timepoint: Stool antigen Helicobacter pylori test 4 weeks after discontinuation of treatment. Method of measurement: Stool antigen Helicobacter pylori test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dyspepsia severity. Timepoint: Before treatment and 4 weeks after treatment. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactreyhane hosseini
Esfahan University of Medical Sciences
Outcome results
None listed